Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Propofol for Emergence Agitation in Nasal Surgery
NCT07265050Not yet recruiting
- Sponsor
- Seoul National University Hospital
- Start
- Jan 2026
- Primary completion
- Dec 2027
- Modality
- Small Molecules
01
Overview
Randomised trial of remimazolam in Emergence agitation (EA) (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Incidence of Emergence Agitation. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on NCT07265050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07265050.